Patent · US Expired

Liposome immunoadjuvants containing IL-2

US5409698A · kind A · utility

26Cited by
25References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 1992
Grant dateApr 25, 1995
Priority date
Expiry dateOct 28, 2012

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S424/812
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a liposome comprising an effective immunoadjuvant amount of a lymphokine such as IL-2. Also provided is an effective antineoplastic amount of IL-2 liposomes in combination with adoptively transferred cells stimulated with anti-CD3 monoclonal antibody plus IL-2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.